semaglutide gallstones risk FDA Data Link Diabetes Drug Class to Gallbladder Disease GLP-1 receptor agonists and gallbladder

Especially during the dark winter days and spending most of your work day under artificial lighting

Mounjaro, which launched in India in March 2025, saw sales increase by 60% in its second month, reaching $1.5 million

Common side effects of Ozempic that are well-documented in the SmPC include: Gastrointestinal symptoms : nausea (very common), vomiting, diarrhoea, abdominal pain, and constipation Hypoglycaemia : particularly when used in combination with insulin or sulfonylureas Injection site reactions : mild and usually transient Fatigue : reported in some patients If you experience severe, persistent abdominal pain (with or without vomiting), seek urgent medical attention as this could indicate pancreatitis, a rare but serious side effect requiring immediate assessment

Semaglutide is a GLP-1 receptor agonist approved by the FDA for managing obesity in adults or those with excess weight accompanied by at least one weight-related condition

Rodent studies repeatedly report that Epitalon administration normalises age-related declines in nocturnal melatonin secretion and restores entrainment of circadian rhythms in old animals